Beijing LabTech Instruments Co Graham Number
The Graham Number of Beijing LabTech Instruments Co (688056.SS) as of Sep 2, 2026 is 12.69 CNY. In the previous year, Graham Number was 10.77 CNY — a change of 17.76% (higher).
Get this data via API
Financial Data API
Graham Number
12.69CNY
YoY
17.76%
Last updated:
Graham Number of Beijing LabTech Instruments Co is 2026 12.69 CNY. Graham Number of Beijing LabTech Instruments Co was 2025 10.77 CNY. It decreases by 17.76% higher compared to the previous year.
The Beijing LabTech Instruments Co Graham Number history
3 Years
10 Years
25 Years
Max
Graham Number
Date
Graham Number
Jan 1, 2017
7.51 CNY
Jan 1, 2018
9.37 CNY
Jan 1, 2019
10.01 CNY
Jan 1, 2020
15.48 CNY
Jan 1, 2021
16.52 CNY
Jan 1, 2022
13.53 CNY
Jan 1, 2023
10.77 CNY
Jan 1, 2024
12.69 CNY
| YEAR | Graham Number | YoY |
|---|---|---|
| 12.69CNY | +17.76% | |
| 10.77CNY | -20.36% | |
| 13.53CNY | -18.09% | |
| 16.52CNY | +6.74% | |
| 15.48CNY | +54.55% | |
| 10.01CNY | +6.89% | |
| 9.37CNY | +24.66% | |
| 7.51CNY | — |
Access this data via the Eulerpool API
Beijing LabTech Instruments Co Stock analysis
What does Beijing LabTech Instruments Co do? Beijing LabTech Instruments Co is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Beijing LabTech Instruments Co stock
Graham Number of Beijing LabTech Instruments Co is 12.69 CNY in 2026.
On Eulerpool you can find the complete historical development of Graham Number Beijing LabTech Instruments Co since 2006 – with annual values, charts, and detailed analysis.
The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.
Access this data via the Eulerpool API
Quality — Beijing LabTech Instruments Co
All Key Metrics — Beijing LabTech Instruments Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth